Governor John Carney (D) signed HB 399 authorizing a pharmacist to order, test, screen and treat certain health conditions pursuant to a statewide written protocol for CLIA-waived tests approved by the Division of Public Health. These health conditions include flu; Strep A; COVID or other respiratory illness, condition or disease; lice; skin conditions including ring worm and athlete’s foot or other emerging and existing public health threats identified and permitted by the Division of Public Health. A pharmacist may also delegate the administration and technical performance of the CLIA-waived test to an intern or pharmacy technician acting under the supervision of the pharmacist.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Office of Controlled Substances Controlled Substance Advisory Committee Meeting scheduled for September 28 is cancelled. The next meeting will be held on November 30 at 9:00 a.m.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

On September 15, Gov. John C. Carney (D) approved the Seventh Extension of Declaration of a Public Health Emergency for the State of Delaware.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Both Houses of the legislature passed SB 399 that authorizes a pharmacist to order, test, screen, and treat certain health conditions pursuant to a statewide written protocol for CLIA waived tests approved by the Division of Public Health. This legislation is pending Governor Carney’s (D) signature.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

The Delaware Controlled Substance Advisory Committee amended the Uniform Controlled Substances Act regulations to make the provisions on expiration and partial filling of controlled substance prescriptions consistent with federal standards. The changes are effect March 11, 2022

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

The Delaware Board of Pharmacy has proposed revisions to its rules and regulations. All comments are due by February 3, 2022. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

The Delaware Division of Professional Regulation is proposing to amend the Uniform Controlled Substances Act regulations to make the provisions on expiration and partial filling of controlled substance prescriptions consistent with federal standards. The rule would make technical revisions. A hearing is scheduled for Dec. 1, 2021, in Dover.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

SB 105 which allows pharmacists to administer or dispense hormonal contraceptives under a standing order from the Division of Public Health was signed into law.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

SB 219, legislation enhancing oversight and transparency related to PBMs, became law this week.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.